NETosis in Parasitic Infections: A Puzzle That Remains Unsolved.

Neutrophils are the key players in the innate immune system, being weaponized with numerous strategies to eliminate pathogens. The production of extracellular traps is one of the effector mechanisms operated by neutrophils in a process called NETosis. Neutrophil extracellular traps (NETs) are complex webs of extracellular DNA studded with histones and cytoplasmic granular proteins. Since their first description in 2004, NETs have been widely investigated in different infectious processes. Bacteria, viruses, and fungi have been shown to induce the generation of NETs. Knowledge is only beginning to emerge about the participation of DNA webs in the host's battle against parasitic infections. Referring to helminthic infections, we ought to look beyond the scope of confining the roles of NETs solely to parasitic ensnarement or immobilization. Hence, this review provides detailed insights into the less-explored activities of NETs against invading helminths. In addition, most of the studies that have addressed the implications of NETs in protozoan infections have chiefly focused on their protective side, either through trapping or killing. Challenging this belief, we propose several limitations regarding protozoan-NETs interaction. One of many is the duality in the functional responses of NETs, in which both the positive and pathological aspects seem to be closely intertwined.

Evidence of reduced academic performance among schoolchildren with helminth infection.

BACKGROUND: Soil-transmitted helminths (STHs) pose a formidable health risk to school-age children in resource-limited settings. Unfortunately, mass deworming campaigns have been derailed since the onset of the coronavirus disease 2019 pandemic. The present study assessed the cross-sectional associations between STHs, nutritional status and academic performance of schoolchildren in the Banda District of Ghana. METHODS: Schoolchildren (5-16 y of age; n=275) were recruited through both school and household visits by community health workers using a multistage cluster sampling technique. In addition to school microscopy, anthropometric records were also taken. RESULTS: The prevalence of geohelminthiasis was 40.4% (95% confidence interval 34.6 to 46.2). STHs targeted for elimination by the World Health Organization and national programmes were detected among schoolchildren. Children with intestinal parasite infection (53.7 [standard deviation {SD} 11.5]) had lower mean academic scores compared with uninfected children (59.6 [SD 16.9]) (p=0.034). In multiple regression analysis, intestinal parasite infection status and z-scores for weight-for-age showed a collective significant effect on the academic score (F1117=8.169, p<0.001, R2=0.125). CONCLUSIONS: Schoolchildren with STHs had poorer academic performance compared with uninfected children, despite their nutritional status. In addition to school feeding programmes, school-based mass drug administration campaigns may be critical for improving learning outcomes in young schoolchildren.

Parasitology and Covid-19: epidemiological, immunological, pathological, and therapeutic aspects

Studies suggest that there is a complex interaction between parasitic infections, human microbiota, and host immunity. Reports have shown that there is the prevalence of viral diseases have inverse correlations with their severities (as is the case for Covid-19), their resulting mortalities, and helminth infections in endemic areas. This review study was conducted to discover the possible association between parasitic infections and Covid-19 epidemics from immunological, pathological, and therapeutic aspects. Our studies were conducted by reviewing texts, reports, and articles on reputable websites such as PubMed, Science Direct, medRxvi, Google Scholar, and bioRxiv published by 2022 07 April for keywords such as a parasite, helminth, radioactive, COVID-19 or SARS-CoV-2. In particular, reports of co-infection with helminths with complications and severity of Covid-19 in endemic areas were considered. The findings indicate that parasitic helminths can regulate host immune responses associated with a viral infection. For example, intestinal parasitic infections may be effective in reducing the symptoms of SARS-CoV-2 and the complications of Covid-19. Infected hosts can induce an innate and Th2-compatible immune response to CD4+ T cells, eosinophils, and interleukins (IL-4, IL-5, and IL-10). Chronic helminth infections prevent strong immune responses by altering the host response to T helper 2 (Th2). Interestingly, some antimalarial drugs, such as Artemisinin-based combination therapies (ACTs), may inhibit SARS-CoV-2-induced severe acute respiratory syndrome (SARS). Parasitic infections may alter the host's immune response to SARS-CoV-2 with potentially beneficial or detrimental effects. However, more large-scale epidemiological studies are needed to uncover the links between parasitic infections and COVID-19 and to clarify existing ambiguities.

Infectious disease Roundup 2022

This paper describes the epidemiology, prevalence, transmission, prevention and control of some infectious diseases in companion animals, livestock, wild animals and humans in Ontario, Canada, in 2022, including SARS-CoV-2;Echinococcus multilocularis, Leishmania spp. and SARS-CoV-2;antimicrobial stewardship resources;2 cases of rabid dogs imported from Iran (July 2021 and January 2022);prevalence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriacea, Dirofilaria immitis, Brucella canis, canine parainfluenza and adeno- and herpes viruses in dogs recently imported from Asia;Paragonimus kellicotti lung flukes and Streptococcus equi subsp. zooepidemicus in dogs;African swine fever in pet pigs, backyard pigs and wild pigs and blastomycosis in dogs and humans.

Schistosomiasis and soil-transmitted helminthiases: progress report, 2021

In 2021, the number of children who required PC for STH decreased for pre-SAC from 291.2 million to 260.6 million and for SAC from 732.3 million to 653.7 million (Figure 2). This change was mainly due to revision of the numbers of children who require PC for STH in India, which decreased from 103.5 to 80.7 million for pre-SAC and from 332.1 to 259.1 million for SAC. The decreases were based on impact assessment surveys conducted in the past few years, which changed the endemicity status of some districts. Globally, PC coverage of SAC increased from 47% in 2020 to 62.9% in 2021.The number of SAC reached with deworming increased almost to that before the COVID-19 pandemic (411 million in 2021, 344 million in 2020, 455.9 million in 2019), indicating that countries are recovering.

Immunological interactions in helminths-SARS CoV-2 coinfection: Could old enemy be a friend today?

Helminths are metazoan parasites affecting about one third of the worldwide population. Chronic helminth infections (CHIs) confer immunological tolerance to harmless and self-antigens mediated by regulatory T cells (Treg) that are up-regulated. In coronavirus disease 2019 (COVID-19), abnormal adaptive immune response and unrestrained innate immune response could result in local and systemic immune-mediated tissue damage. COVID-19 and CHIs establish complicated immune interactions due to SARS-CoV-2-induced immunological stimulation and CHIs-induced immunological tolerance. However, COVID-19 severity in patients with CHIs is mild, as immuno-suppressive anti-inflammatory cytokines counterbalance the risk of cytokine storm. Here, an overview of the interplay between helminths and COVID-19 severity is given. CHIs through helminth-derived molecules may suppress SARS-CoV-2 entry and associated hyperinflammation through attenuation of the TLR4/NF-kB signalling pathway. In addition, CHIs may reduce the COVID-19 severity by reducing the SARS-CoV-2 entry points at ACE2/DPP4/CD147 axis in the initial phase and immunomodulation in the late phase of the disease by suppressing TLR4/NF-kB signalling pathway.

Possession of exotic animals and zoonotic diseases: an approach from the Mexican context

The possession of exotic animals as pets is a social practice that has become more visible in Mexico in recent years, so it is interesting to understand its environmental and social implications and those related to human health. The present study aims to identify the main species of exotic animals kept as pets and the zoonotic diseases reported in these species. We analyzed official figures of seizures of exotic fauna in Mexico and reviewed specialized literature on zoonotic diseases documented in Mexico in these species. We identified zoonoses in species of fauna that can be acquired legally and illegally in the country, reported in environments in which animals coexist with other species and are in direct contact with people, which represents an important factor in the spread and propensity of this type of disease. We conclude that the sanitary regulation of wildlife markets, the monitoring and studying microorganisms associated with wildlife are valuable strategies to prevent the emergence of zoonoses.

Differentiating infectious from non-infectious respiratory disease in the cat and dog

This paper describes the clinical signs and use of differential laboratory diagnostic techniques (computed tomography, cytology, histopathology, antigen/antibody detection and polymerase chain reaction) for infectious (viral, bacterial, fungal and parasitic) and non-infectious (inflammatory/immune mediated, neoplastic, cardiac, malformation, foreign body, smoke inhalation, aspiration of caustic material, non-cardiogenic, pulmonary oedema, traumativ, pneumothorax, pulmonary contusions and idiopathic) causes of respiratory diseases in cats and dogs in Ontario, Canada.

Role of neglected parasitic diseases in the era of COVID-19 pandemics

There are some doubts about the exact relationship between neglected infectious diseases (NIDs) and COVID-19 disease, which remains to be clearly defined. The present review summarized the effect of parasitic infections as the risk factors or protective agents in the COVID-19 pandemic. Parasites could proficiently modulate immune responses. Thus, parasitic infections could have a different impact on the incidence and clinical severity of COVID-19 in different regions of the world. Also, restoring programs to prevent, treat, and control NIDs, in particular helminths, could help in reducing the incidence and mortality of COVID-19 in endemic areas and help to increase vaccination effectiveness. Changes in the gut microbiome associated with helminth infection may have systemic immunomodulatory effects toward suppressing host immune responses, reducing vaccine efficacy and increasing the severity of other infectious diseases. The cytokine storm observed in severe cases of COVID-19 is characterized by a predominance of proinflammatory cytokines, such as IL-6. However, it is possible that helminth infection could change the outcome of infection by modifying the Th2 response to limit the inflammatory component;this would be particularly apparent in areas endemic for helminthic infections, which suggests a possible protective effect against COVID-19. Because parasitic infections affect more than 2 billion people throughout the world, their impact on COVID-19- associated effects on public health could be considerable. Further studies with larger sample sizes would be needed to explore the possible role of neglected parasitic infections in the COVID-19 pandemic.

Elimination of human onchocerciasis: progress report, 2021

This progress report provides an update on the progress made towards eliminating nnchocerciasis (river blindness) by the World Health Organization (WHO) as part of its road map on neglected tropical diseases for 2021-2030. The report highlights that the goal is to eliminate the need for mass drug administration of ivermectin in at least one focus in 34 countries by 2030, in more than 50% of the population in at least 16 countries and in the entire endemic population in at least 12 countries. However, challenges remain in achieving these goals, including incomplete mapping of all transmission zones, co-endemicity of onchocerciasis and loiasis, a potential decrease in sensitivity to ivermectin, uncoordinated cross-border work, suboptimal programme implementation and inadequate technical and financial resources. COVID-19 has also delayed national programmes, with millions of doses of preventive chemotherapy that should have been distributed expiring. The report also provides regional highlights, including that in 2021, 23 countries reported having treated a total of 142.3 million people for onchocerciasis, representing 58.1% of global coverage, and that the African region faces the greatest challenge with 99% of the global burden of the disease in this region.

Diagnostic challenges during pandemic: a case report

Hydatid cyst is an infection caused by the parasite Echinococcus granulosus, which is seen endemic in animal husbandry areas. Due to the heavy burden on physicians during the pandemics, diseases other than COVID-19 took a back seat during the differential diagnosis of patients. Hydatid cyst is located in the bone at a rate of 1-4%. The symptoms and imaging features of the cyst located in the bone are not specific, thus they are less likely to be considered in the differential diagnosis of extremity lesions. The absence of a specific clinical picture and the lack of high sensitivity of the indirect hemagglutination test bring radiological evaluations to the fore in diagnosis. In this case report, we shared diagnostic and treatment process of a patient-who was first admitted to the hospital with edema, pain and fever in the leg, was diagnosed with multisystem inflammatory syndrome in children (MIS-C) later diagnosed hydatid cyst with lung and bone involvement.

Summary of the 31st meeting of the international task force for disease eradication, 20-21 October 2020

This article provides a brief overview of the 31st meeting of the International TaskForce for Disease Eradication (ITFDE) that was convened at The Carter Center in Atlanta, GA, USA on 20-21 October 2020 to discuss "The impact of the COVID-19 pandemic on eradication and elimination programmes and the way forward." It highlights the results of 7 eradication programmes, with specific conclusions and recommendations for each: Guinea Worm Eradication Programme(dracunculiasis;GWEP);Global Polio Eradication Initiative (GPEI);elimination programmes for measles and rubella (MR), malaria, river blindness (onchocerciasis;RB), and lymphatic filariasis (LF);and the program for the Global Elimination of Trachoma.

Progress in eliminating onchocerciasis in the WHO region of the Americas: disruption of ivermectin mass drug administration in the Yanomami focus area due to the COVID-19 pandemic

This article describes how the COVID-19 pandemic significantly reduced provision of treatment in the Yanomami focus area (YFA) in 2020, especially in the Bolivarian Republic of Venezuela. The distribution of ivermectin for mass treatment (MDA) to prevent onchocerciasis was affected worldwide by the COVID-19 pandemic in 2020, as were MDA programs for other neglected tropical diseases (NTDs). On 1 April 2020, WHO recommended that mass treatment campaigns, active case-finding, and population-based surveys for NTDs be postponed until further notice to reduce the risk of COVID-19 transmission associated with large-scale community health interventions. The Carter Center, which provides major funding to MDA in the Bolivarian Republic of Venezuela, temporarily halted its activities in 2020 due to an administrative problem and, once the COVID-19 pandemic had taken hold, in order to adhere to WHO recommendations, its own policies, and the policies of other donor organizations. Ivermectin treatment continued to be offered in Brazil, supported by the government, with essential health services such as vaccination and malaria control. On 27 July 2021, WHO released new interim guidance for NTD programs. This included a risk-benefit analysis to figure out if activities could be resumed safely and detailed standards for reducing risk with all known precautions (such as wearing masks, socialdistance, hand sanitizing and/or handwashing, limiting live meetings and group size). The program in the Bolivarian Republic of Venezuela followed these instructions and made a plan to get back to work safely, which was what WHO wanted.

Global programme to eliminate lymphatic filariasis: progress report, 2020

This article describes the Global Programme to Eliminate Lymphatic Filariasis (GPELF), which aims to stop the spread of infection by mass drug administration (MDA) and ease the suffering of patients through morbidity management and disability prevention (MMDP). In 2020, LFMDA treated 21.6 million 2-4-year-olds and 98.5 million 5-14-year-olds. Given the impact of LF MDA on soil-transmitted helminth (STH) infections, WHO advises adding STH infection assessment into transmission assessment surveys (TAS) to increase NTD intervention efficiency. Once preTAS and TAS standards are met, an IU's population no longer needs MDA. 692 million people didn't need MDA. This 49% decline in LF cases is a huge step toward meeting the Sustainable Development Goal (SDG). Thirteen countries and 171 IUs performed TASs in 2020. A total of 4316 TAS have been conducted in EUs, which are greater or smaller than IUs. 100% of EUs passed a TAS, according to 2020 reports (the proportion of children who tested positive for LF infection was below the threshold for considering transmission unsustainable). Several 2020 TAS were postponed because to COVID-19 pandemic restrictions. Despite a global epidemic, GPELF achieved progress in 2020, demonstrating the resolve and inventiveness of national LFprogrammes to end this illness.

Elimination of human onchocerciasis: progress report, 2020

In this report, four countries (Colombia, Ecuador, Guatemala, and Mexico) have completed the WHO-recommended process for verification of the interruption of human onchocerciasis transmission, and many others have ceased mass drug administration (MDA), completed post-treatment surveillance (PTS), or both in at least one transmission area on their territory. Interruption of transmission enabled governments to preserve the benefits acquired over many years of effective MDA with Ivermectin and to discontinue MDA permanently, thereby protecting populations living in endemic areas from morbidity and infection. The eradication of human onchocerciasis would contribute significantly to achieving Sustainable Development Goal (SDG) 3.3, which calls for the eradication of neglected tropical diseases (NTDs) by 2030. All countries endemic for onchocerciasis have reported instances of COVID-19. The impact of the pandemic on NTD interventions has been discussed elsewhere. In many countries, scheduled MDA rounds were postponed due to efforts to prevent the spread of SARS-CoV-2 in onchocerciasis-endemic nations. In 2020, 26.9% fewer patients were treated for onchocerciasis than in 2019. MDA was implemented in fewer nations and implementation units in 2020 (1096 versus 1538 in 2019), resulting in a 27.7% decrease in global geographical coverage. The WHO Global Health Observatory provides access to data submitted by governments.

Surveillance and trends of soil-transmitted helminth infections in Liaoning Province, 2016-2020

Objective: To investigate the prevalence and transmission of soil-transmitted helminth (STH) in Liaoning Province, in order to provide scientific evidence for development of control plans, strategies and measures aagainst these diseases in Liaoning Province.

A systematic review and meta-analysis on global prevalence of infectious diseases in backyard chicken in the recent two decades

Backyard poultry is evolving as a fast-growing sector in recent times across the world. Apart from providing nutritional security, and livelihood to marginalized sector, also fulfils the demand for organic and welfare meat and eggs. However, the productivity is often challenged by incidences of diseases due to poor biosecurity and lack of vaccination. In this study, systematic review and meta-analysis were performed on the global prevalence of infectious diseases in backyard chickens. A total of 22 bacterial, viral, parasitic and fungal diseases were reported from 55 publications between 2000 and 2020 worldwide. Viral diseases were the most reported followed by bacterial and parasitic diseases. 61 out of 91 studies from 55 publications investigated seven major diseases: Avian influenza (AI), Newcastle disease (ND), infectious bronchitis (IB), Mycoplasma gallisepticum (MG), Mycoplasma synoviae (MS), Salmonella infection, and infectious laryngotracheitis (ILT). The overall pooled prevalence estimate for all the diseases worldwide was 33% (95% confidence interval (CI): 28-38). The pooled estimates for most reported viral diseases AI and ND were 12.5% (95% CI: 7-18) and (30% CI: 19-43), respectively. IBD (71% CI: 13-100), MS (76% CI: 67-85) and helminth infestations (72% CI: 44-93) were the highly prevalent diseases among viral, bacterial and parasitic infections, respectively. The continent wise pooled prevalence ranged from 17 to 32%. The present results will help in devising the best possible strategies to minimize the disease risk for commercial poultry and humans as well as for improving the productivity of backyard poultry farming.

Various surgical interventions in cases of complicated hepatic echinococcosis with intracystic bile leakage

Objective: To explore an effective surgical intervention strategy for hepatic echinococcosis complicated with intracystic bile leakage.

Parasite immunomodulatory role in reducing the prevalence of COVID-19 in endemic regions

Nearly 35 million cases and one million deaths over the nine months of the COVID-19 pandemic have been reported worldwide. Africa and some countries with endemic parasitic infections had a low incidence of COVID-19. By contrast, the United States and several European countries, having a non-endemicity of parasitic infections, recorded a high incidence of COVID-19. Some parasites have an immunomodulatory mechanism that can induce an immune tolerance state in the infected persons by balancing pro-inflammatory and anti-inflammatory responses. Emerging reports also stated that COVID-19 and helminth co-infections may have more hidden outcomes than predictable ones. Hence, the aim of this literature review is to show and identify that an increase in the number of regulatory immune cells due to the immunomodulatory role of a pre-existing parasitic infection could reduce the risk of COVID-19. This study explored the existing literature to determine the role of parasitic infections in modulating the immune response and possibly reduce the risk of COVID-19 infection in endemic countries. The mechanism of immunomodulation by parasites is the increased numbers of Treg cells, M2 macrophages, eosinophils, the Th2 cytokines IL-4 and IL-5, and the pro-inflammatory downregulation of IFN lambda, TNF alpha, and IL-6, which play an essential role in inducing cytokine storms in COVID-19 infection. This condition will probably occur in an individual with parasitic infection in a community with limited facilities and infrastructure to treat parasitic infections, particularly in developing countries. To conclude, in endemic areas, the immunomodulatory effect of parasitic infection to reduce the risk of COVID-19 cases/deaths is a possibility if the host is immunocompetent. Herein, the current knowledge on the immunomodulatory role of COVID-19 and helminth co-infections will be discussed.